Virax Biolabs Group Limited Ordinary Shares (VRAX)

About VRAX

Sector

Health Care

Industry

Biotechnology: In Vitro & In Vivo Diagnostic Substances

Website

www.viraxbiolabs.com

Fundamentals

Market cap

$2.21M

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-23.09

Dividend yield

—

Beta

1.44

Avg. volume

—

Virax Biolabs Group Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

• VRAX

  Virax Biolabs Group Limited Ordinary Shares

  $2.82

  ▼ 4.08%
  Market cap $2.21MP/E —
  $2.5$21.75
• CDIO

  Cardio Diagnostics Holdings Inc. Common stock

  $1.84

  ▼ 1.60%
  Market cap $4.91MP/E —
  $0.97$7.91
• BMRA

  Biomerica Inc. Common Stock

  $2.14

  ▲ 1.67%
  Market cap $4.94MP/E —
  $1.45$3.31
• VNRX

  VolitionRX Limited Common Stock

  $0.45

  ▼ 10.00%
  Market cap $9.23MP/E —
  $0.3269$14.8
• QCLS

  Q/C Technologies Inc. Common Stock

  $2.37

  ▲ 0.00%
  Market cap $21.99MP/E —
  $2.3$8.94
• IMDX

  Insight Molecular Diagnostics Inc. Common Stock

  $4.16

  ▼ 3.03%
  Market cap $154.99MP/E —
  $2.33$8.51
• TKNO

  Alpha Teknova Inc. Common Stock

  $7.13

  ▼ 2.46%
  Market cap $350.10MP/E —
  $1.91$7.84

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• What's going on in today's after hours session
  ChartMill · 8/19/2026
• 12 Health Care Stocks Moving In Wednesday's After-Market Session
  Benzinga · 8/19/2026
• 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  Benzinga · 8/19/2026